Patents Assigned to ARMATA PHARMACEUTICALS, INC.
  • Therapeutic bacteriophage compositions for treating infection
    Patent number: 11654166
    Abstract: The present disclosure relates to a bacteriophage composition comprising one or more (suitably two or more, or three) obligately lytic bacteriophages capable of infecting and lysing Staphylococcus aureus, and use of the same for treating Staphylococcus aureus bacterial infections.
    Type: Grant
    Filed: January 2, 2019
    Date of Patent: May 23, 2023
    Assignee: ARMATA PHARMACEUTICALS, INC.
    Inventors: Sandra P. Morales, Gillian Mearns, Deborah A. Rankin, Frenk Smrekar
  • Therapeutic bacteriophage compositions
    Patent number: 11253557
    Abstract: The present invention relates to a bacteriophage composition comprising one or more (suitably two or more, or three) bacteriophages selected from Sa87, J-Sa36, Sa83, J-Sa37, or mutants thereof, use of the same for medical or non-medical applications, kits, bandage, and wound dressing comprising the same.
    Type: Grant
    Filed: December 27, 2019
    Date of Patent: February 22, 2022
    Assignee: ARMATA PHARMACEUTICALS, INC.
    Inventors: Karen Joy Shaw, Sandra P. Morales, Gillian Mearns, Deborah A. Rankin, Frenk Smrekar
  • Therapeutic bacteriophage compositions
    Patent number: 10517908
    Abstract: The present invention relates to a bacteriophage composition comprising one or more (suitably two or more, or three) bacteriophages selected from Sa87, J-Sa36, Sa83, J-Sa37, or mutants thereof, use of the same for medical or non-medical applications, kits, bandage, and wound dressing comprising the same.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: December 31, 2019
    Assignee: ARMATA PHARMACEUTICALS, INC.
    Inventors: Karen Joy Shaw, Sandra P. Morales, Gillian Mearns, Deborah A. Rankin, Frenk Smrekar